Two types of receptor sites are theorized to explain adrenergic effects.
Alpha-Receptors
- Alpha-receptors are associated mainly with increased contractibility of vascular smooth muscle and intestinal relaxation.
Alpha1
- The alpha1 is located at postsynaptic effector sites to stimulate transmitter release in smooth muscle. For example, the smooth muscle of peripheral blood vessels is contracted in alpha1 stimulation.
Alpha2
- The alpha2 receptor site is located presynaptic on axon terminals to inhibit the release of nor-epinephrine (the transmitter). The effects of alpha2 stimulation results in relaxation of the intestinal tract--motility and tone are decreased.
Beta-Receptors
- Beta-receptors are associated with vasodilation and relaxation of nonintestinal smooth muscle and cardiac stimulation.
- Beta1 Stimulation of beta1 receptor sites results in cardiac stimulation and lipolysis.
- Beta2 Stimulation of beta2 receptor sites causes bronchodilation, relaxation of blood vessels (usually in skeletal muscles), and muscle glycogenolysis.
Alpha Receptor Site: Important features of the site include in order of importance: - An anionic site - which binds the positive ammonium group.
- One hydrogen bonding area
- A flat area non-polar area for the aromatic ring.
Beta Receptor Site: Important features of the site include in order of importance - also see the graphic on the left: - An anionic site - shown as Asp anionic negative acid group which binds the positive ammonium group.
- Two hydrogen bonding areas - shown as two Serine with alcohol (OH) groups hydrogen bonding to the phenol OH groups of the NE.
- A flat area non-polar area for the aromatic ring.
Tissue | Receptor Subtype | Agonists | Antagonists |
Heart | beta1 | NE, EP, dobutamine, xamoterol | atenolol, metoprolol. |
Adipose tissue | beta1, beta 3? |
|
|
Vascular Smooth Muscle | beta 2 | EP, salbutamol, terbutaline, salmeterol | butoxamine |
Airway Smooth Muscle | beta 2 | terbutaline, salbutamol, salmeterol and zinterol, | butoxamine |
Smooth muscle contraction | alpha 1 | NE, EP, phenylephrine, oxymetazoline) | prazosin, doxazocin |
Inhibition of
transmitter release Hypotension, anaesthesia, Vasoconstriction | alpha 2 | clenbuterol, alpha-methylnoradrenaline, dexmedetomidine, and mivazerol, clonidine, clenbuterol | yohimbine, idazoxan, atipamezole, efaroxan, and rauwolscine |
Receptor Sites |
alpha-receptor | beta-receptor |
Vasoconstriction | vasodilation (b2) |
iris dilation | cardioacceleration (b1) |
intestinal relaxation | intestinal relaxation (b2) |
intestinal sphincter
contraction | uterus relaxation(b2) |
bladder sphincter contraction | bronchodilation (b2) |
|
0 comments:
Post a Comment